AbCellera Biologics(ABCL) - 2024 Q1 - Quarterly Results

NEWS RELEASE AbCellera Reports Q1 2024 Business Results 05/07/2024 VANCOUVER, British Columbia--(BUSINESS WIRE) -- AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “We continue to execute on advancing our internal pipeline, completing capital investments in forward integration, and expanding strategic partnerships,” said Carl Hansen, Ph.D., founder and CEO of AbCe ...